Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-10-07FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Sam's West Inc)
FDA approved a supplemental application for the Nicotine Transdermal System (nicotine patch) submitted by Sam's West Inc.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Extinction Updating in Reconsolidation [NA]
Clinical trial on extinction updating in reconsolidation for nicotine dependence and smoking cessation has completed.
-
FDA approval · 2015-09-30FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC. This action updates the existin…
-
FDA approval · 2015-09-30FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nicorette (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2015-09-30FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved Lil' Drug Store's supplemental application for Nicorette 4 mg Fruit Chill Gum (nicotine polacrilex). The product is intended as…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-30FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex gum) submitted by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers [NA]
An internet-delivered smoking cessation program was studied in overweight and obese smokers. Results were posted in September 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007) [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating an unnamed Merck research drug as an aid for smoking cessation…
-
CLINICAL_TRIALS trial_result · 2015-09-18Clinical Trial Update: Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion Paradigm [NA]
Clinical trial update reporting test-retest reproducibility of [11C]PHNO PET using a constant infusion paradigm; results posted after comple…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Effects of rTMS on Cigarette Smoking and Cognition in Schizophrenia [NA]
A completed clinical trial evaluating the effects of repetitive transcranial magnetic stimulation (rTMS) on cigarette smoking behavior and c…
-
CLINICAL_TRIALS research · 2015-08-25Clinical Trial Update: In-patient Smoking Cessation Intervention Using Counseling, Spirometry and Nicotine Replacement Therapy [NA]
Clinical trial update on an inpatient smoking cessation intervention using counseling, spirometry, and nicotine replacement therapy, sponsor…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Tobacco Quit Line Re-enrollments for the Underserved [NA]
A completed clinical trial evaluating tobacco quit line re-enrollment for underserved populations.
-
FDA approval · 2015-08-10FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2015-08-06FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Sam's West Inc)
FDA approved a supplemental application for the Nicotine Transdermal System submitted by Sam's West Inc.
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers [Phase 2]
Phase 2 trial evaluating moclobemide as an adjunct to nicotine replacement therapy in female smokers. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Prazosin for Smoking Cessation [Phase 2]
The Phase 2 trial of prazosin for smoking cessation in nicotine dependence was terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Patient Experience Recommender System for Persuasive Communication Tailoring [NA]
This Clinical Trial Update describes a patient experience recommender system designed to tailor persuasive communication for smoking cessati…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence [Phase 4]
This Phase 4 effectiveness trial evaluated maintenance therapy for nicotine dependence. The study has completed and results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Galantamine Effects on Nicotine Responses in Smokers [Phase 1]
A Phase 1 trial from Yale University assessed whether galantamine modulates nicotine responses in smokers; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients [NA]
This clinical trial update reports on the effectiveness of smoking-cessation interventions among urban hospital patients.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders [NA]
The contingency management trial for smoking cessation among veterans with psychotic disorders has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-06-15Clinical Trial Update: Project Quit: Positive vs. Negative Offers of an Online Stop Smoking Program [NA]
The study compared positive and negative offers of an online stop-smoking program to assess their effect on quit outcomes; results were post…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Assessment of a Teachable Moment for Smoking Cessation
A clinical trial evaluated a teachable moment approach to promote smoking cessation in individuals with nicotine dependence, and results wer…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia [Phase 4]
Phase 4 trial evaluating extended duration nicotine replacement therapy with bupropion in smokers with schizophrenia was terminated.
-
FDA approval · 2015-05-16FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Apnar Pharma LP's generic Bupropion hydrochloride, confirming approval to market the product wit…